Providing equitable and sustainable access to vital scientific and medical information
Elsevier believes everyone should have an equal opportunity to access quality scientific and medical information regardless of their economic situation, social class, ethnicity, background or physical disabilities- something we call universal access. Elsevier has made significant investments in access initiatives and technology to expand access to subscription content. For full details see our list of initiatives below and for feedback and queries please contact email@example.com
Corporate and SME
Corporate and SME access
- Tailored products: Corporate organizations have different access needs and Elsevier has developed a number of tailored products to help extract information in formats which enable better decisions and grater innovation.View all products.
- Transactional: Articles can be ordered and delivered in electronic or print format via pay-per-view, a credit card-based article purchasing option. Other options include DeepDyve.
- UK Pilot for Small and medium-sized enterprises (SMEs): To help understand the needs for small businesses ( less than 25 full time employees), we are running two access pilots with Biocity and Sci-Tech. Read more about SME access on Elsevier Connect.
Public & Patients
Public & Patient Access
- Journalist access: Research articles published in Elsevier's journals are regularly distributed to 1,500 journalists. With unrestricted media access, we help the media break leading stories relevant for the public and assist them in delivering the latest science and medical news internationally.
- Open content: Elsevier has a number of publishing programs which enable free unrestricted access to readers. This includes our open access content and contact made available through our open archives. Read more
- Nobel Tribute: In recognition of these extraordinary scholars, we have made a collection of their work, published with Elsevier, freely available. Read more
- PatientInform: Since 2006 we have also provided access to medical research in 100 journals directly to the public through this program. Read more
- Patient Access: We also participate in a pilot where patients or their caregivers can register and for a small handling fee receive research papers via email.
- Walk in access: Our ScienceDirect platform is also available to the public via walk-in user access from any participating university library. We are also participating in the Access to Research program, where we provide access through local public libraries.
- Transactional: Through DeepDyve and CCC, members of the public can rent access to articles from over 250 of Elsevier's journals at a very low cost. A 24-hour article rental to read-only PDF is provided at a price per article between $0.99 and $3.99. Individuals can order articles to be delivered in electronic or print format via pay-per-view, a credit card-based article purchasing option
- Guest user access means you can access and read all abstracts and citations on ScienceDirect for free; you can even sign in on ScienceDirect to set up alerts and manage preference. Read more
Access for the developing world
- Provide free and low cost access to more than 2000 Elsevier journals and 7,000 Elsevier e-books through Research4Life. Each year this program accounts for over 3 million downloads across Elsevier content from researchers in developing countries. Read more
- Elsevier journals are also made free to access through the International Centre Theoretical Physics (ICTP) eJournals Delivery Service which provides a technical solution for scientists working in developing countries that do not have access to sufficient bandwidth or cannot afford to digitally connect to content. This is available for individual scientists in developing countries working in the fields of physics, mathematics and computer science.
- In partnership with the Royal Tropical Institute (KIT) we provide 150 researchers working in fields such as tropical medicine and sustainable development in the least-developed and low-income countries with access to both ScienceDirect and Scopus.
- For open access publishing, we also have a waiver policy in place which gives preference for researchers from eligible countries in the Research4Life program.
Access for early career researchers and students
- Postdoc access program: Provides access to ScienceDirect for scholars who have their PhD's but who currently do not have a research position allowing young researchers the opportunity to remain competitive for new research positions. Read more.
- Accessible formats for print disabilities: We provide alternate files to help students with print disabilities worldwide. Campus disability services may use the AccessTextNetwork or the Elsevier Disability Request Form to request a file.
Access for researchers
- ScienceDirect Access: Elsevier publishes approximately 2400 subscription journals and provides access to over 14 million researchers. Our online journal platform, ScienceDirect, hosts 10 million articles dating back to the 1820s and now has close to 600 million full text article downloads per year. Elsevier has developed a number of licensing options, including the freedom and subject collections and pay per view. These give customers flexibility in the way they purchase access. Read more
- Open Access Publishing: Elsevier has an established open access program since 2006, which now includes 1600 hybrid journals and over 100 open access titles. Read more
- Share link: Authors who publish with Elsevier receive a share link of their published article, providing 50 days free access to their article on ScienceDirect. Read more
- Transactional: Elsevier offers options to purchase single articles (Pay-per-view) and groups of articles (Article Choice). We also work in partnership with document delivery suppliers such as Ingenta and Subito.
- Walk in access: Our ScienceDirect platform is also available to the public via walk-in user access from any participating library.
- Open data pilot: We also make raw research data freely available for users to download and use alongside the article. Read more
Helping fight Ebola
To assist health workers, researchers and the general public, Elsevier is participating in a number of initiatives to bring this outbreak to a close. These include:
|The Lancet Ebola Resource Centre: This hub brings together existing Ebola content from The Lancet journals and Cell Press and will feature the latest Ebola research as it is published. It is intended to be a comprehensive Ebola resource for clinicians, public health professionals, and anybody else who needs access to existing Ebola research and latest developments. All content on the site is free to access. Read more|
Ebola Information Center: Elsevier's free health and medical research, online tools and expert advice on Ebola available from Elsevier Connect. The center was developed to give our readers – medical professionals, health researchers, and members of the public interested in Ebola – one place where they can access the depth and breadth of Elsevier's resources on the Ebola virus. Read more
|Access to ClinicalKey: ClinicalKey is a search engine that provides evidence-based clinical answers drawn from the single largest body of clinical content available, including Medline, 600+ journals, 1,100+ books, drug information, guidelines, and patient education. For West Africa, Elsevier is granting free access for the next two months. Read more.|
|Emergency Access Initiative (EAI): Elsevier is participating is the joint collaboration between the National Library of Medicine (NLM) and publishers which has been activated to support healthcare professionals working on the Ebola public health emergency in West Africa.This provides free access to full-text from over 650 biomedical journals and over 4,000 reference books and online databases to healthcare professionals and libraries affected by disasters.|
|Research4Life: Provides free and low-cost access to the researchers in developing|
countries. It is central to Elsevier's goal of achieving universal access and as a founding partner and the leading contributor, we make all of ScienceDirect and Scopus- including over 2,000 journals and 6,000 books - available through Research4life. Read more